SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Jing-Hui Tian(Novavax (United States)), Gale Smith(Novavax (United States))
Cited by 524
Related Papers
Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
|Vaccines|2020|22
Flexible RSV prefusogenic fusion glycoprotein exposes multiple neutralizing epitopes that may collectively contribute to protective immunity
|bioRxiv (Cold Spring Harbor Laboratory)|2020|10